Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas

Nuclear Medicine Communications

Volumn 31, Issue 3, 2010, Pages 195-200

  Wu, Hu Bing ^a   Wang, Quan Shi ^a   Wang, Ming Fang ^a   Li, Hong Sheng ^a   Zhou, Wen Lan ^a   Ye, Xiang Hua ^a   Wang, Qiao Yu ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

18F fluorodeoxyglucose; Computed tomography; Natural killer T cell lymphoma; Positron emission tomography; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NK T CELL LYMPHOMA; RECURRENT CANCER; TUMOR BIOPSY; BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; LABORATORY DIAGNOSIS; METHODOLOGY; MIDDLE AGED; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; STANDARD; T CELL LYMPHOMA;

ADULT; AGED; BIOPSY; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA, T-CELL; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 76749155455     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32833310fa     Document Type: Article

References (20)

1. Suzuki R, Takeuchi K, Ohshima K, Nakamura S. Extranodal NK/T-cell lymphoma: diagnosis and treatment cues. Hematol Oncol 2008; 26:66-72.
2. Al-Hakeem DA, Fedele S, Carlos R, Porter S. Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol 2007; 43:4-14.
3. Chan JK, Sin VC,Wong KF, Ng CS, Tsang WY, Chan CH, et al., Non-nasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997; 89:4501-4513.
4. Li YX, Fang H, Liu QF, Lu J, Qi SN, Wang H, et al., Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. Blood 2008; 112:3057-3064.
5. Wu X, Li P, Zhao J, Yang X,Wang F, Yang YQ, et al., A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type. Clin Oncol (R Coll Radiol) 2008; 20:619-625.
6. Allen-Auerbach M, De Vos S, Czernin J. The impact of fluorodeoxyglucosepositron emission tomography in primary staging and patient management in lymphoma patients. Radiol Clin North Am 2008; 46:199-211.
7. Terasawa T, Nihashi T, Hotta T, Nagai H. 18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic review. J Nucl Med 2008; 49:13-21.
8. Jaffe ES, Harris NL, Stein H, Vardiman Je. Pathology and genetics of tumours of haematopoietic and lymphoid tissue. Tumours of haematopoietic and lymphoid tissues, World health organization classification of tumours. Lyon: IARC; 2001. pp. 121-253.
9. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31:1860-1861.
10. Kako S, Izutsu K, Ota Y, Minatani Y, Sugaya M, Momose T, et al., FDG-PET in T-cell and NK-cell neoplasms. Ann Oncol 2007; 18:1685-1690.
11. Khong PL, Pang CB, Liang R, Kwong YL, Au WY. Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Ann Hematol 2008; 87:613-621.
12. Karantanis D, Subramaniam RM, Peller PJ, Lowe VJ, Durski JM, Collins DA, et al., The value of [(18)F] fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma. Clin Lymphoma Myeloma 2008; 8:94-99.
13. Suh C, Kang YK, Roh JL, Kim MR, Kim JS, Huh J, et al., Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/ T-Cell lymphomas of the head and neck. J Nucl Med 2008; 49:1783-1789.
14. Berk V, Yildiz R, Akdemir UO, Akyurek N, Karabacak NI, Coskun U, et al., Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging. Clin Nucl Med 2008; 33:365-366.
15. Even-Sapir E, Lievshitz G, Perry C, Herishanu Y, Lerman H, Metser U. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease. Radiol Clin North Am 2007; 45:697-709.
16. Rini JN, Leonidas JC, Tomas MB, Palestro CJ. 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med 2003; 44:1072-1074.
17. Toaff JS, Metser U, Gottfried M, Gur O, Deeb ME, Lievshitz G, et al., Differentiation between malignant and benign pleural effusion in patients with extra-pleural primary malignancies: assessment with positron emission tomography-computed tomography. Invest Radiol 2005; 40:204-209.
18. Pakos EE, Fotopoulos AD, Ioannidis JP. 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. J Nucl Med 2005; 46:958-963.
19. Chim CS, Ma SY, Au WY, Choy C, Lie AK, Liang R, et al., Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 2004; 103:216-221.
20. Nakagawa T, Yamada M, Suzuki Y. 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles. J Nucl Med 2008; 49:1053-1059.